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1. Introduction 
The transcription of bacteriophage @Xl 74 has been 
actively investigated in recent years. In phage infected 
E. coli cells Hayashi and Hayashi [ 1,2] have identified 
10 discrete 1$X174 specific RNA components with 
mol. wts. ranging from 3.0 X lo6 to about 0.2 X 106. 
Recent studies on size and number of @Xl 74 RNA 
conducted by Clements and Sinsheimer [3] have 
demonstrated the presence of 18 distinct RNA species 
within the same range of molecular weight. In contrast 
to these observations RNA synthesized in vitro using 
E. coli RNA polymerase and $X174 RF DNA as a 
template had a different size distribution [4] . Each 
of the in vitro RNAs was larger than the complete 
transcript of the @Xl 74 genome (1.7 X 1 O6 dalton). 
Addition of the termination factor p to the RNA- 
synthesizing system resulted in a decrease of the 
RNA’s size to that of in vivo RNA. However, even in 
the presence of p factor several ow mol. wt. RNAs 
identified in vivo were missing in vitro. We suggested 
that these RNAs might originate as a result of a 
cleavage of the initial RNA transcripts by the special 
enzyme, RNAase III. The involvement of the RNAase 
III in the processing of T7-early RNA and ribosomal 
RNA precursor was observed recently [ 5-71. In this 
paper we describe the effect of the p factor and 
RNAase III on the transcription of @X174 RF1 DNA 
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in vitro. It is shown that in the RNA polymerase 
system containing @Xl 74 RF1 DNA, p factor, and 
RNAase III a set of RNAs is synthesized that is very 
similar in size distribution to the @X174 RNAs from 
infected cells. 
2. Methods 
2.1. Enzymes 
RNA polymerase holoenzyme was purified from 
E. coli MRE 600 cells by the method of Burgess [8] 
with slight modifications, p factor and RNAase III 
were purified according to the method of Darlix [9] 
including the glycerol gradient sedimentation. 
2.2. DNA of bacteriophage @Xl 74 
RF1 DNA was isolated from E. coli C infected with 
wild type $J X1 74 by the procedure developed in our 
laboratory. This involved gentle 1ysozymeSDS lysis 
followed by selective precipitation of high mol. wt. 
host DNA with I .2 M NaCI, phenol treatment, gel 
filtration on a Sepharose 2B column, chromatography 
on a methylated serum albumin-kieselguhr column 
and glycerol gradient sedimentation. 
2.3. RNA synthesis in vitro 
“C-Labelled @X RNA was synthesized in the 
standard reaction mixture containing (per ml): 
40 pmol TrisHCl pH 7.9, 20 pmol MgCl*, 150 pmol 
NaCl, 0.1 pmol EDTA, 0.1 pmol dithiothreitol, 0.2 
pmol (each) ATP, GTP and CTP, 0.1 pmole [ 14C] 
UTP (20 &i/pmole), 12 gg @Xl 74 RF1 DNA and 
24 pg RNA polymerase (1500 units/mg [S]). p Factor 
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and/or RNAase III were added as indicated in figure 
legends. The reaction mixtures were incubated for 
15 min at 37°C and then 20 Mg of RNAase-free 
DNAase (Worthington) was added. After a further 
10 min. incubation at 0°C SDS was added to 0.5%. 
RNA was extracted by phenol treatment according 
to Kirby [lo]. 
2.4. Gel electrophoresis of ( “C]RNA 
Gel electrophoresis was performed in composite 
gels (2.4% acrylamide, 0.5% agarose, 0.1% SDS) as 
described by Bishop [l l] . In vitro synthesized RNA 
l-----------l 
a 
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Fraction No 
was dissolved in 30% glycerol- 1% SDS and 5 ~1 
samples were placed on gels. After the run (8 mA/gel, 
80 min) gels were frozen and sliced to 2 mm discs. 
Radioactivity of the discs was measured in toluene- 
absolute ethanol scintillation fluid with a Mark II 
liquid scintillation counter. 
3. Results and discussion 
RNA synthesized in vitro using highly purified 
E coli RNA polymerase and @X174 RF1 DNA as a 
I 
Fraction No 
Fig. 1. Size distributions of OX174 RNA synthesized in vitro. The conditions of RNA synthesis, isolation and gel electrophoresis 
were as described in Methods. Arrows show the position of 23s and 16s ribosomal RNA markers. RNA synthesized in vitro (a) 
without factors, (b) with 1 ng p factor, (cl with 20 pg RNAase III and (d) with 1 fig p factor and 20 I.rg RNAase III. 
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template was analysed in SDS-polyacrylamide- 
agarose gel electrophoresis (fig. la). High mol. wt. 
RNAs synthesized in this system had a characteristic 
discrete size distribution; at least five species of RNA 
were usually observed. The largest of them had a mol. 
wt. of approximately 3.0 X 106, i.e. it was a product 
of about two rounds of @X174 genome transcription, 
and the smallest one was of 1.6 X 106 dalton, i.e. 
corresponded to the product of about one round of 
transcription. In our RNA preparations we were failed 
to detect any considerable amounts of material with 
a size larger than 3.0 X lo6 dalton, as was observed 
by Hayashi et al. [4] in a similar system. This 
discrepancy was probably a result of a longer incu- 
bation time in Hayashi’s experiments. 
Thus size distribution of the in vitro RNAs (fig.la) 
was very different from the distribution of virus- 
induced RNAs [l-3], as most of the in vivo RNA 
species had molecular weights less than 1.6 X 1 06. 
It seems that the formation of #X174 RNA in 
infected cells is under the control of some additional 
factors for instance of termination p factor. The 
addition of p factor to RNA-synthesizing system in 
vitro resulted in a drastic alteration of RNA size 
(fig. 1 b). In this case RNA species with molecular 
weights higher than 1.6 X lo6 disappeared com- 
pletely and only smaller molecules were present. A 
similar decrease of RNA size in the presence of p 
factor was previously reported by Hayashi [4]. In 
both cases the sizes of RNA produced in the system 
containing p factor were within the size range of 
in vivo RNA. However several species observed in the 
preparations of in vivo RNA (mainly with a low mol. 
wt.) were missing from this pattern. 
The formation of low mol. wt RNA in the infected 
cells might be a result of the cleavage of preformed 
RNA by a special enzyme. It was demonstrated [S-7] 
that early T7 RNA and ribosomal RNA precursor 
were cleaved by an enzyme, RNAase III into discrete 
RNA species. If RNAase III has a role in sizing 
@X174 RNAs in vivo it may be possible to mimic this 
situation in vitro. Assuming that all possible initiation 
and termination events take place in the cell-free 
RNA-synthesizing system with p factor, we can try 
to obtain all in vivo RNA species if both termination 
p factor and RNAase III are present. The size distribu- 
tion of in vitro RNAs synthesized in the presence of 
both p factor and RNAase III shown in fig.ld. It may 
r 
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Fig.2. Size distribution of double-labelled @X174 RNA 
synthesized in vitro. All conditions were as in fig. 1 except 
that the concentrations of RF1 DNA, RNA polymerase, 
ribonucleoside triphosphates, p factor and RNAase III were 
two times higher and 200 pCi [ y-“‘P]CTP were also added. 
Symbols: (-o--a-) [“CIRNA counts, (-m-m-) [3*P]RNA 
counts. 
be seen that the relative amount of RNA with a mol. 
wt. less than 0.6 X lo6 increased and at least two 
new species of RNA appeared in the region of fractions 
33-38. These effects became even more pronounced 
if the concentrations of DNA, RNA polymerase, p 
factor and RNAase III were elevated (tig.2). 
The size distribution of RNA shown in fig.2 is in 
good agreement with that reported by Hayashi for 
the in vivo system [2]. The same distribution was 
obtained not only as a result of simultaneous action 
of p factor and RNAase III during the synthesis, but 
when RNA was synthesized with p factor alone, 
isolated and then treated with RNAase III (data not 
shown). If only RNAase III was present in the RNA- 
synthesizing system the gel pattern of the RNA 
product (fig.1) differed from those shown in fig.ld 
and fig.2, though some material was present in 
fractions 34-39. 
Our results suggest hat RNAase III patticipates in 
processing of @Xl 74 RNA in vitro. It is reasonable to 
assume that RNAase III also participates in the forma- 
tion of @Xl 74 specific RNAs in vivo. Stronger support 
for this assumption may well be found in experiments 
with @X174 infected E. coli strains deficient in RNA- 
ase III. 
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It is not clear at present which RNA species are 
the targets of RNAase III action. The analysis of 
5’-termini of individual RNAs may be useful in the 
solution of this problem. We confirmed the observa- 
tion [ 121 that not only [Y-~~P] ATP and [y-32P]GTP 
but also [-Y-~~P]CTP is incorporated into $X174 RNA 
synthesized in vitro, and showed that in the system 
containing p factor and RNAase III virtually all 
incorporated [T-~~P] CTP is found in a single RNA 
species (fig.2). This RNA component is a product of 
RNAase III action. 
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